✦ LIBER ✦

Chronic granulomatous disease of childhood: Gastric manifestation and response to salazosulfapyridine therapy

✍ Scribed by J. Stopyrowa; K. Fyderek; B. Sikorska; D. Kowalczyk; M. Zembala

Publisher: Springer
Year: 1989
Tongue: English
Weight: 769 KB
Volume: 149
Category: Article
ISSN: 0340-6997
DOI: 10.1007/bf02024330

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pulmonary manifestations of Fabry diseas

Pulmonary manifestations of Fabry disease and positive response to enzyme replacement therapy

✍ Woojin Kim; Reed E. Pyeritz; Barbara A. Bernhardt; Michael Casey; Harold I. Litt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

Expression of thrombopoietin and its rec

Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia : Correlation with disease progression and response to therapy

✍ Kerim Kaban; Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Jorge Cortes; Franci 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

BACKGROUND. Chronic myelogenous leukemia (CML) represents a paradigm of the stepwise increment in disease aggressiveness, resistance to therapy, and transformation. Thrombopoietin (TPO) and its receptor, c-mpl, support the proliferation of multiple types of immature hematopoietic progenitor cells, a

Severity of liver disease predicts the d

Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy

✍ Wassim Chehadeh; Widad Al-Nakib 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

## Abstract A higher prevalence of glucose abnormalities has been reported in patients with hepatitis C virus (HCV) infection compared to patients with hepatitis B virus (HBV) infection. However, previous studies considered some confounding factors and ignored others, which might influence the comp